Bracing NK cell based therapy to relegate pulmonary inflammation in COVID-19

The contagiosity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has startled mankind and has brought our lives to a standstill. The treatment focused mainly on repurposed immunomodulatory and antiviral agents along with the availability of a few vaccines for prophylaxis to vanquish...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeyaraman, Madhan, Muthu, Sathish, Bapat, Asawari, Jain, Rashmi, Sushmitha, E.S., Gulati, Arun, Channaiah Anudeep, Talagavadi, Dilip, Shirodkar Jaswandi, Jha, Niraj Kumar, Kumar, Dhruv, Kesari, Kavindra Kumar, Ojha, Shreesh, Dholpuria, Sunny, Gupta, Gaurav, Dureja, Harish, Chellappan, Dinesh Kumar, Singh, Sachin Kumar, Dua, Kamal, Jha, Saurabh Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294777/
https://www.ncbi.nlm.nih.gov/pubmed/34312598
http://dx.doi.org/10.1016/j.heliyon.2021.e07635

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294777/
https://www.ncbi.nlm.nih.gov/pubmed/34312598
http://dx.doi.org/10.1016/j.heliyon.2021.e07635

Ejemplares similares